Natural Transmission of Plasmodium berghei Exacerbates Chronic Tuberculosis in an Experimental Co-Infection Model

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Mueller, Ann Kristin ^b   Behrends, Jochen ^a   Hagens, Kristine ^a   Mahlo, Jacqueline ^a   Schaible, Ulrich E ^a   Schneider, Bianca E ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE STORM; DISEASE EXACERBATION; EXPERIMENTAL INFECTION; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOREGULATION; LEUKOCYTE; LUNG TUBERCULOSIS; MIXED INFECTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM BERGHEI INFECTION;

ANIMALS; CHRONIC DISEASE; COINFECTION; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; LIVER; LUNG; MALARIA; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM BERGHEI; PNEUMONIA; SPLEEN; T-LYMPHOCYTES; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM BERGHEI;

EID: 84868153284     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048110     Document Type: Article

References (73)

1. Cooper AM, (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27: 393-422.
2. Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, et al. (2008) Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 205: 105-115.
3. Lin PL, Plessner HL, Voitenok NN, Flynn JL, (2007) Tumor necrosis factor and tuberculosis. J Investig Dermatol Symp Proc 12: 22-25.
4. Ulrichs T, Kaufmann SH, (2006) New insights into the function of granulomas in human tuberculosis. J Pathol 208: 261-269.
5. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413-431.
6. Schofield L, Grau GE, (2005) Immunological processes in malaria pathogenesis. Nat Rev Immunol 5: 722-735.
7. Mohan A, Sharma SK, Bollineni S, (2008) Acute lung injury and acute respiratory distress syndrome in malaria. J Vector Borne Dis 45: 179-193.
8. Hoffman SL, Doolan DL, (2000) Malaria vaccines-targeting infected hepatocytes. Nat Med 6: 1218-1219.
9. Mueller AK, Labaied M, Kappe SH, Matuschewski K, (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433: 164-167.
10. Mueller AK, Deckert M, Heiss K, Goetz K, Matuschewski K, et al. (2007) Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am J Pathol 171: 107-115.
11. Nussenzweig RS, Vanderberg J, Most H, Orton C, (1967) Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 216: 160-162.
12. Van den Steen PE, Geurts N, Deroost K, Van Aelst I, Verhenne S, et al. (2010) Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome. Am J Respir Crit Care Med 181: 957-968.
13. Lovegrove FE, Gharib SA, Pena-Castillo L, Patel SN, Ruzinski JT, et al. (2008) Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog 4: e1000068.
14. Craig AG, Grau GE, Janse C, Kazura JW, Milner D, et al. (2012) The role of animal models for research on severe malaria. PLoS Pathog 8: e1002401.
15. Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, et al. (1999) Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect 1: 961-968.
16. Eum SY, Kong JH, Hong MS, Lee YJ, Kim JH, et al. (2009) Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137: 122-128.
17. Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, et al. (2006) NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol 177: 7086-7093.
18. Korbel DS, Schneider BE, Schaible UE, (2008) Innate immunity in tuberculosis: myths and truth. Microbes Infect 10: 995-1004.
19. Schneider BE, Korbel D, Hagens K, Koch M, Raupach B, et al. (2010) A role for IL-18 in protective immunity against Mycobacterium tuberculosis. Eur J Immunol 40: 396-405.
20. Corleis B, Korbel D, Wilson R, Bylund J, Chee R, et al. (2012) Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils. Cell Microbiol.
21. Sugawara I, Udagawa T, Yamada H, (2004) Rat neutrophils prevent the development of tuberculosis. Infect Immun 72: 1804-1806.
22. Barrios-Payan J, Aguilar-Leon D, Lascurain-Ledezma R, Hernandez-Pando R, (2006) [Neutrophil participation in early control and immune activation during experimental pulmonary tuberculosis]. Gac Med Mex 142: 273-281.
23. Pedrosa J, Saunders BM, Appelberg R, Orme IM, Silva MT, et al. (2000) Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun 68: 577-583.
24. Fulton SA, Reba SM, Martin TD, Boom WH, (2002) Neutrophil-mediated mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice. Infect Immun 70: 5322-5327.
25. Petrofsky M, Bermudez LE, (1999) Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response. Clin Immunol 91: 354-358.
26. Barnes PF, Leedom JM, Chan LS, Wong SF, Shah J, et al. (1988) Predictors of short-term prognosis in patients with pulmonary tuberculosis. J Infect Dis 158: 366-371.
27. Condos R, Rom WN, Liu YM, Schluger NW, (1998) Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 157: 729-735.
28. Keller C, Hoffmann R, Lang R, Brandau S, Hermann C, et al. (2006) Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun 74: 4295-4309.
29. Eruslanov EB, Lyadova IV, Kondratieva TK, Majorov KB, Scheglov IV, et al. (2005) Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun 73: 1744-1753.
30. Cruz A, Fraga AG, Fountain JJ, Rangel-Moreno J, Torrado E, et al. (2010) Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med 207: 1609-1616.
31. Osuchowski MF, Welch K, Siddiqui J, Remick DG, (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177: 1967-1974.
32. Sriskandan S, Altmann DM, (2008) The immunology of sepsis. J Pathol 214: 211-223.
33. van der Poll T, de Waal Malefyt R, Coyle SM, Lowry SF, (1997) Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis 175: 118-122.
34. Gogos CA, Drosou E, Bassaris HP, Skoutelis A, (2000) Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181: 176-180.
35. Rittirsch D, Flierl MA, Ward PA, (2008) Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8: 776-787.
36. Couper KN, Blount DG, Riley EM, (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777.
37. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, et al. (2008) IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 4: e1000004.
38. Langhorne J, Albano FR, Hensmann M, Sanni L, Cadman E, et al. (2004) Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev 201: 35-47.
39. de Souza JB, Hafalla JC, Riley EM, Couper KN, (2010) Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 137: 755-772.
40. Bogdan C, Vodovotz Y, Nathan C, (1991) Macrophage deactivation by interleukin 10. J Exp Med 174: 1549-1555.
41. Flesch IE, Hess JH, Oswald IP, Kaufmann SH, (1994) Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int Immunol 6: 693-700.
42. Gazzinelli RT, Oswald IP, James SL, Sher A, (1992) IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 148: 1792-1796.
43. Oswald IP, Wynn TA, Sher A, James SL, (1992) Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci U S A 89: 8676-8680.
44. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, et al. (2000) IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105: 1317-1325.
45. Murray PJ, Young RA, (1999) Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 67: 3087-3095.
46. Redford PS, Boonstra A, Read S, Pitt J, Graham C, et al. (2010) Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol 40: 2200-2210.
47. O'Leary S, O'Sullivan MP, Keane J, (2011) IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. Am J Respir Cell Mol Biol 45: 172-180.
48. Herbst S, Schaible UE, Schneider BE, (2011) Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One 6: e19105.
49. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, et al. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 94: 5243-5248.
50. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA, (1997) T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 158: 315-321.
51. Schreiber T, Ehlers S, Heitmann L, Rausch A, Mages J, et al. (2009) Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol 183: 1301-1312.
52. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG, (1998) Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol 161: 2636-2641.
53. Bingisser R, Stey C, Weller M, Groscurth P, Russi E, et al. (1996) Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. Am J Respir Cell Mol Biol 15: 64-70.
54. Rojas M, Olivier M, Gros P, Barrera LF, Garcia LF, (1999) TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J Immunol 162: 6122-6131.
55. Arcila ML, Sanchez MD, Ortiz B, Barrera LF, Garcia LF, et al. (2007) Activation of apoptosis, but not necrosis, during Mycobacterium tuberculosis infection correlated with decreased bacterial growth: role of TNF-alpha, IL-10, caspases and phospholipase A2. Cell Immunol 249: 80-93.
56. Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, et al. (2011) Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol 4: 279-287.
57. Beamer GL, Flaherty DK, Assogba BD, Stromberg P, Gonzalez-Juarrero M, et al. (2008) Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol 181: 5545-5550.
58. Turner J, Gonzalez-Juarrero M, Ellis DL, Basaraba RJ, Kipnis A, et al. (2002) In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 169: 6343-6351.
59. Jamil B, Shahid F, Hasan Z, Nasir N, Razzaki T, et al. (2007) Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 87: 279-287.
60. Flynn JL, Chan J, (2001) Tuberculosis: latency and reactivation. Infect Immun 69: 4195-4201.
61. Ray JC, Flynn JL, Kirschner DE, (2009) Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J Immunol 182: 3706-3717.
62. Zhou Z, Connell MC, MacEwan DJ, (2007) TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 19: 1238-1248.
63. Algood HM, Lin PL, Flynn JL, (2005) Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 41 (Suppl 3): S189-193.
64. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, et al. (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168: 4620-4627.
65. Scott CP, Kumar N, Bishai WR, Manabe YC, (2004) Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model. Am J Trop Med Hyg 70: 144-148.
66. Hawkes M, Li X, Crockett M, Diassiti A, Conrad Liles W, et al. (2010) Malaria exacerbates experimental mycobacterial infection in vitro and in vivo. Microbes Infect 12: 864-874.
67. Vaughan JA, Scheller LF, Wirtz RA, Azad AF, (1999) Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials. Infect Immun 67: 4285-4289.
68. Murphy JR, (1981) Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation. Infect Immun 33: 199-211.
69. Smrkovski LL, Strickland GT, (1978) Rodent malaria: BCG-induced protection and immunosuppression. J Immunol 121: 1257-1261.
70. Page KR, Jedlicka AE, Fakheri B, Noland GS, Kesavan AK, et al. (2005) Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific. Infect Immun 73: 8369-8380.
71. Colombatti R, Penazzato M, Bassani F, Vieira CS, Lourenco AA, et al. (2011) Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau. BMC Infect Dis 11: 57.
72. Vanderberg JP, (1974) Studies on the motility of Plasmodium sporozoites. J Protozool 21: 527-537.
73. Vanderberg JP, (1975) Development of infectivity by the Plasmodium berghei sporozoite. J Parasitol 61: 43-50.